{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:47:05Z","timestamp":1780332425998,"version":"3.54.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1989,3,1]],"date-time":"1989-03-01T00:00:00Z","timestamp":604713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1989,3,1]],"date-time":"1989-03-01T00:00:00Z","timestamp":604713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1989,3,1]],"date-time":"1989-03-01T00:00:00Z","timestamp":604713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1989,3,1]],"date-time":"1989-03-01T00:00:00Z","timestamp":604713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med. Oncol. & Tumor Pharmacother."],"published-print":{"date-parts":[[1989,3]]},"DOI":"10.1007\/bf02985221","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:03:47Z","timestamp":1589468627000},"page":"31-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic application of calf thymus extract (TFX)"],"prefix":"10.1007","volume":"6","author":[{"given":"Aleksander B.","family":"Skotnicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02985221_CR1","first-page":"97","volume":"7","author":"J Aleksandrowicz","year":"1975","unstructured":"Aleksandrowicz J, Turowski G, Czarnecki J, Szmigiel Z, Cybulski L, Skotnicki A B: Thymic factor X (TFX) as a biologically active extract.Ann Immun\n                  7, 97 (1975).","journal-title":"Ann Immun"},{"key":"BF02985221_CR2","first-page":"475","volume":"26","author":"J Czarnecki","year":"1978","unstructured":"Czarnecki J, Jaskolski B: Preparation TFX-Polfa Jelenia Gora.Arch Immun Ther Exp\n                  26, 475 (1978).","journal-title":"Arch Immun Ther Exp"},{"key":"BF02985221_CR3","first-page":"1119","volume":"33","author":"A B Skotnicki","year":"1978","unstructured":"Skotnicki A B: The biological activity and physicochemical properties of the thymus extract TFX.Pol Tyg Lek\n                  33, 1119 (1978).","journal-title":"Pol Tyg Lek"},{"key":"BF02985221_CR4","first-page":"477","volume":"26","author":"K Staroscik","year":"1978","unstructured":"Staroscik K, Boratynski J, Lisowski J: Properties of TFX, a product obtained from calf thymus.Arch Immun Ther Exp\n                  26, 477 (1978).","journal-title":"Arch Immun Ther Exp"},{"key":"BF02985221_CR5","first-page":"827","volume":"28","author":"S Slopek","year":"1980","unstructured":"Slopek S, Gieldanowski J, Kowalczyk-Bronisz S H: Immunobiological and pharmacological properties of thymus factor X (TFX). I. Biological and pharmacological activity.Arch Immun Ther Exp\n                  28, 827 (1980).","journal-title":"Arch Immun Ther Exp"},{"key":"BF02985221_CR6","first-page":"483","volume":"26","author":"J Gieldanowski","year":"1978","unstructured":"Gieldanowski J, Kowalczyk-Bronisz S H: Investigations on immunological and pharmacological activities of thymus factor X (TFX).Arch Immun Ther Exp\n                  26, 483 (1978).","journal-title":"Arch Immun Ther Exp"},{"key":"BF02985221_CR7","first-page":"853","volume":"28","author":"J Gieldanowski","year":"1980","unstructured":"Gieldanowski J, Slopek S, Kowalczyk-Bronisz H: Immunological and pharmacological properties of thymus factor X (TFX). II. Immunotroplc activity.Arch Immun Ther Exp\n                  28, 853 (1980).","journal-title":"Arch Immun Ther Exp"},{"key":"BF02985221_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/978-1-4684-4745-3_55","volume-title":"Thymic Hormones and Lymphokines","author":"A B Skotnicki","year":"1984","unstructured":"Skotnicki A B, Dabrowska-Bernstein B K, Dabrowski M P, Gorski A, Czarnecki J, Aleksandrowicz J: Biological properties and clinical use of calf thymus extract TFX-Polfa, in Goldstein A L (ed):Thymic Hormones and Lymphokines, pp. 545\u2013564, New York, Plenum Press (1984)."},{"key":"BF02985221_CR9","first-page":"53","volume":"4","author":"J W Goodman","year":"1978","unstructured":"Goodman J W, Basford N L, Shinpock S G: On the role of thymus in hemopoietic differentiation.Blood Cells\n                  4, 53 (1978).","journal-title":"Blood Cells"},{"key":"BF02985221_CR10","first-page":"389","volume":"3","author":"D Zipori","year":"1975","unstructured":"Zipori D, Trainin N: The role of thymic humoral factor in the proliferation of bone marrow CFU-S from thymectomized mice.Exp Hemat\n                  3, 389 (1975).","journal-title":"Exp Hemat"},{"key":"BF02985221_CR11","first-page":"387","volume":"26","author":"W Jaszcz","year":"1975","unstructured":"Jaszcz W, Chlap Z, Turowski G, Piotrowska K: Studies on biologic activity of thymic extract (TFX). I. Effect on the blood plcture and lymphatic organs in mice.Patol Pol\n                  26, 387 (1975).","journal-title":"Patol Pol"},{"key":"BF02985221_CR12","first-page":"51","volume":"41","author":"M Wazewska-Czyzewska","year":"1977","unstructured":"Wazewska-Czyzewska M, Aleksandrowicz J, Szybinski Z, Kulig D, Plonka I, Skotnicki A B: The effect of calf thymus extract TFX, on the survival of mice exposed on ionizing radiation.Pol Przegl Rad Med nukl\n                  41, 51 (1977).","journal-title":"Pol Przegl Rad Med nukl"},{"key":"BF02985221_CR13","first-page":"273","volume":"31","author":"W Jaszcz","year":"1980","unstructured":"Jaszcz W, Rzepecki W, Wojceiwski Z, Piotrowska K: The effect of TFX on the plctures of the blood and lymphatic organs of thymectomized mice in the postneonatal period.Patol Pol\n                  31, 273 (1980).","journal-title":"Patol Pol"},{"key":"BF02985221_CR14","first-page":"4696","volume":"39","author":"A B Skotnicki","year":"1980","unstructured":"Skotnicki A B, Gorski A, Gaciong Z, Korczak G: The effect of thymus extract onin vitro proliferation of hematopoietic progenitor cells.Fedn Proc Fedn Ann Soc exp Biol\n                  39, 4696 (1980).","journal-title":"Fedn Proc Fedn Ann Soc exp Biol"},{"key":"BF02985221_CR15","first-page":"129","volume":"3","author":"A Gorski","year":"1981","unstructured":"Gorski A, Skornicki A B, Gaciong Z, Korczak G: The effect of calf thymus extract TFX on mouse and human hemopoiesis.Thymus\n                  3, 129 (1981).","journal-title":"Thymus"},{"key":"BF02985221_CR16","first-page":"319","volume":"33","author":"G Raberger","year":"1985","unstructured":"Raberger G, Gieldanowski J: The influence of thymus factor X (TFX) and its fraction V on the haemodynamic and haemopoietic functions.Arch Immun Ther Exp\n                  33, 319 (1985).","journal-title":"Arch Immun Ther Exp"},{"key":"BF02985221_CR17","unstructured":"Miszta H, Dabrowski Z, Zdunczyk A, Skotnicki A B, Piastucka B: Biological response modifiers influence the PHA-induced production of CSF by human peripheral blood lymphocytes, inSymposium Haematologicum, Zakopane, Nov. 6\u20137, Abstracts, p. 45 (1984)."},{"key":"BF02985221_CR18","unstructured":"Aleksandrowicz J, Blicharski J, Janicki K, Lisiewicz J, Skotnicki A B, Sliwczynska B, Turowski G, Szmigiel Z, Wazewska-Czyzewska M: Effect of the thymus extract on congenital hypogammaglobulinaemia and immunological deficiency accompanying the proliferative and aplastic haematological diseases, in van Bekkum D K (ed):Biological Activity of Thymus Hormones, pp. 37\u201339. Rotterdam, Kooyker (1975)."},{"key":"BF02985221_CR19","first-page":"95","volume":"37","author":"A B Skotnicki","year":"1987","unstructured":"Skotnicki A B, Blicharski J, Lisiewicz J, Sasiadek U, Janik J, Wolska T, Zdunczyk A, Aleksandrowicz J: Calf thymus extract TFX-Polfa in the treatment of patients with secondary leukopenia.Ther Drugs\n                  37, 95 (1987).","journal-title":"Ther Drugs"},{"key":"BF02985221_CR20","unstructured":"Zeromski J, Slowik-Gabryelska A, Krzysko R: The preliminary evaluation of TFX administration in advanced bronchogenic carcinoma, inSeminar on Cellular and Humoral Immunity in Lung Diseases, pp. 44\u201346. Poznan (1976)."},{"key":"BF02985221_CR21","first-page":"350","volume":"2","author":"W Stankiewicz-Szymczak","year":"1986","unstructured":"Stankiewicz-Szymczak W, Moszynski B, Dabrowski M P, Dabrowska-Bernsztein B K, Stasiak A: The initial results of TFX-Polfa application in patients with chronic recurrent infections of upper respiratory tract.Pol J Otolaryng\n                  2, 350 (1986).","journal-title":"Pol J Otolaryng"},{"key":"BF02985221_CR22","unstructured":"Matusiewicz R, Wasniewski J, Kowalczyk M, Lebiedowski K, Czajkowski M: The effect of TFX-Polfa on peripheral blood granulocyte migration and phagocytize ability in patients receiving long term steroid therapy, in Chyrek-Borowska S (ed):Immunomodulation (Bialowieza), p. 47. Polish Immunological Society (1987)."},{"key":"BF02985221_CR23","first-page":"121","volume":"29","author":"J Gieldanowski","year":"1981","unstructured":"Gieldanowski J: Immunomodulators \u2014 Thymus Factor X (TFX) and levamisole in immune reactions and inflammatory processes.Arch Immun Ther Exp\n                  29, 121 (1981).","journal-title":"Arch Immun Ther Exp"},{"key":"BF02985221_CR24","first-page":"247","volume":"8","author":"W Kiczka","year":"1983","unstructured":"Kiczka W, Lawniczak C, Szkaradkiewicz A, Czarnecki J, Pesic M: Thymic extracts stimulate phagocytosis of granulocytes and macrophages.Immun Pol\n                  8, 247 (1983).","journal-title":"Immun Pol"},{"key":"BF02985221_CR25","first-page":"271","volume":"7","author":"H Wysocki","year":"1985","unstructured":"Wysocki H, Kiczka W, Wierusz-Wysocka B, Szczepanik A, Czarnecki J: The influence of thymus extract (TFX) on the phagocytic and the bactericidal capacity of polymorphonuclear neutrophils from patients with insulin-dependent diabetes mellitus.Thymus\n                  7, 271 (1985).","journal-title":"Thymus"},{"key":"BF02985221_CR26","first-page":"257","volume":"4","author":"E M Smogorzewska","year":"1985","unstructured":"Smogorzewska E M, Korczynska M, Golebiowska J: The effect of calf thymus extract (TFX) on human T lymphocyte and neutrophil mobility and chemotactic responsein vitro.Thymus\n                  4, 257 (1985).","journal-title":"Thymus"},{"key":"BF02985221_CR27","unstructured":"Radomska G, Jankowski A, Prusek W: Immunomodulation in children with recurrent infections of respiratory tract, in Chyrek-Borowska S (ed):Immunomodulation (Bialowieza), p. 46, Polish Immunological Society (1987)."},{"key":"BF02985221_CR28","unstructured":"Trybus-Galuszka H, Osenko G, Gedliczka O, Turowski G: Immunomodulation in patients with severe life-threatening states hospitalized in intensive care unit, in Chyrek-Borowska S (ed):Immunomodulation (Bialowieza), p. 41. Polish Immunological Society (1987)."},{"key":"BF02985221_CR29","unstructured":"Kiczka W, Szulc R, Jurczyk W, Lawniczak Cz, Gaca M: TFX Polfa in the treatment of patients with sepsis or septic shock, in:4th World Congress on Intensive and Critical Care Medicine, Jerusalem, Abstract 45. (1985)."},{"key":"BF02985221_CR30","unstructured":"Kiczka W, Juszczyk J, Adamek J, Ozynski R: Thymic factor X (TFX) in the treatment of acute and chronic active hepatitis type B, in:IX International Congress of Infections and Parasitic Diseases (Munich) (1986)."},{"key":"BF02985221_CR31","first-page":"1085","volume":"39","author":"J Juszczyk","year":"1984","unstructured":"Juszczyk J: Preliminary evaluation of the therapeutic results in patients with chronic active hepatitis (HBsAg+) receiving calf thymus extract (TFX-Polfa).Pol Tyg Lek\n                  39, 1085 (1984).","journal-title":"Pol Tyg Lek"},{"key":"BF02985221_CR32","first-page":"192","volume":"42","author":"W Kiczka","year":"1987","unstructured":"Kiczka W, Juszczyk J, Actamek J: The therapeutic results of TFX in patients with chronic active hepatitis.Pol Tyg Lek\n                  42, 192 (1987).","journal-title":"Pol Tyg Lek"},{"key":"BF02985221_CR33","first-page":"71","volume":"29","author":"B K Dabrowska-Bernstein","year":"1980","unstructured":"Dabrowska-Bernstein B K, Dabrowski M P, Cianciara J, Brzosko W J, Babiuch L, Kassur B: The treatment of chronic aggressive hepatitis with Polish Thymus Factor (TFX).Erfahrungsheilkunde\n                  29, 71 (1980).","journal-title":"Erfahrungsheilkunde"},{"key":"BF02985221_CR34","first-page":"1097","volume":"39","author":"J Cianciara","year":"1984","unstructured":"Cianciara J, Babiuch L, Gorska E, Kassur B: Immunotherapy of patients with chronic active hepatitis (HBsAg+) with TFX. Clinical opinion.Pol Tyg Lek\n                  39, 1097 (1984).","journal-title":"Pol Tyg Lek"},{"key":"BF02985221_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0090-1229(80)90135-X","volume":"16","author":"M P Dabrowski","year":"1980","unstructured":"Dabrowski M P, Dabrowska-Bernstein B K, Brzosko W J, Babiuch L, Kassur B: Immunotherapy of patients with chronic virus B hepatitis. I. Maturation of human T-lymphocytes under influence of calf thymic hormone.Clin Immun Immunopath\n                  16, 297 (1980).","journal-title":"Clin Immun Immunopath"},{"key":"BF02985221_CR36","unstructured":"Skotnicki A B, Hoszowska B, Szerla J, Biedowa E: The effect of calf thymus extract TFX-Polfa on clinical and laboratory parameters in patients with rheumatoid arthritis, in:Abstracts, 6th International Congress Immunology, p. 679. Toronto (1986)."},{"key":"BF02985221_CR37","unstructured":"Rutowicz L: TFX in the treatment of patients with rheumatoid arthritis, in Chyrek-Borowska S (ed):Immunomodulation (Bialowieza), p. 38. Polish Immunological Society (1987)."},{"key":"BF02985221_CR38","first-page":"1363","volume":"13","author":"J Aleksandrowicz","year":"1981","unstructured":"Aleksandrowicz J, Blicharski J, Retinger M, Skot-nicki A B, Zdunczyk Z: Some aspects of immunopathogenesis of multiple sclerosis and therapeutic perspectives.Pol Tyg Lek\n                  13, 1363 (1981).","journal-title":"Pol Tyg Lek"},{"key":"BF02985221_CR39","first-page":"345","volume":"37","author":"A B Skotnicki","year":"1983","unstructured":"Skotnicki A B: Immunoregulatory treatment in autoimmunoaggressive syndromes.Post Hig Med Dosw\n                  37, 345 (1983).","journal-title":"Post Hig Med Dosw"},{"key":"BF02985221_CR40","first-page":"345","volume":"37","author":"A B Skotnicki","year":"1983","unstructured":"Skotnicki A B, Aleksandrowicz J, Retinger-Grzesiula M, Zdunczyk A, Grochmal S, Huczynski J: Multiple sclerosis: immune pathogenesis, up to date therapeutic strategy and the combined immunoregulatory treatment.Post Hig Med Dosw\n                  37, 345 (1983).","journal-title":"Post Hig Med Dosw"},{"key":"BF02985221_CR41","unstructured":"Hertmanowska H, Zielinska M, Kutzner K, Skotnicki A B: The combined immunomodulatory treatment in patients with multiple sclerosis, in:Abstracts. Second International Workshop on Neuroimmunomodulation, p. 126. Dubrovnik (1986)."},{"key":"BF02985221_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1749-6632.1987.tb35832.x","volume":"496","author":"M P Dabrowski","year":"1987","unstructured":"Dabrowski M P, Dabrowska-Bernstein B K, Stasiak A, Gajkowski K, Korniluk S: Immunologic and clinical evaluation of multiple sclerosis patients treated with corticosteroids and\/or calf thymic hormones.Ann N Y Acad Sci\n                  496, 697 (1987).","journal-title":"Ann N Y Acad Sci"},{"key":"BF02985221_CR43","first-page":"209","volume":"4","author":"G Turowski","year":"1987","unstructured":"Turowski G, Sanokowska E, Dynowska D, Kapinska-Mrowka M, Chomiak-Stachura E: Influence of TFX on immunological response and clinical course of patients with psoriasis.Prog Dermal, Poznan\n                  4, 209 (1987).","journal-title":"Prog Dermal, Poznan"},{"key":"BF02985221_CR44","unstructured":"Kapinska-Mrowka M, Turowicz G: Clinical observations of patients with psoriasis treated with TFX, in Chyrek-Borowska S (ed):Immunomodulation (Bialowieza), p. 49. Polish Immunological Society (1987)."},{"key":"BF02985221_CR45","first-page":"225","volume":"4","author":"B Stepien","year":"1987","unstructured":"Stepien B, Bowszyc J, Janicka D, Zaba R: TFX-Polfa in the treatment of patients with scleroderma.Prog Dermat, Poznan\n                  4, 225 (1987).","journal-title":"Prog Dermat, Poznan"},{"key":"BF02985221_CR46","first-page":"389","volume":"13","author":"A Stasiak","year":"1983","unstructured":"Stasiak A: Successful immunotherapy with TFX-Polfa in a patient with acute dermatomyositis.Pol Tyg Lek\n                  13, 389 (1983).","journal-title":"Pol Tyg Lek"},{"key":"BF02985221_CR47","first-page":"1103","volume":"40","author":"A Zdunczyk","year":"1985","unstructured":"Zdunczyk A, Aleksandrowicz J, Skotnicki A B: An attempt to treat dermatomyositis with TFX-Polfa.Pol Tyg Lek\n                  40, 1103 (1985).","journal-title":"Pol Tyg Lek"},{"key":"BF02985221_CR48","first-page":"199","volume":"4","author":"G Turowski","year":"1987","unstructured":"Turowski G, Dynowska D, Sanokowska E: Influence of thymic extract (TFX-Polfa) on selected skin diseases.Prog Dermat, Poznan,4, 199 (1987).","journal-title":"Prog Dermat, Poznan"},{"key":"BF02985221_CR49","first-page":"233","volume":"4","author":"B Stepien","year":"1987","unstructured":"Stepien B, Janicka D, Bowszyc J, Zaba R: Dermatomyositis treated with Polish thymic preparation TFX.Prog Dermat, Poznan\n                  4, 233 (1987).","journal-title":"Prog Dermat, Poznan"},{"key":"BF02985221_CR50","first-page":"226","volume":"8","author":"D Dynowska","year":"1983","unstructured":"Dynowska D, Sanokowska E, Turowski G: The effect of thymus extract (TFX) on atoplc dermatitis.Immun Pol\n                  8, 226 (1983).","journal-title":"Immun Pol"},{"key":"BF02985221_CR51","first-page":"97","volume":"17","author":"M Wazewska-Czyzewska","year":"1976","unstructured":"Wazewska-Czyzewska M, Aleksandrowicz J, Turowski G, Blichski J, Dobrowolski J, Dolezalowa M: A trial of immunological stimulation with thymic extract (TFX) in untreated chronic lymphocytic leukemia.Acta Med Pol\n                  17, 97 (1976).","journal-title":"Acta Med Pol"},{"key":"BF02985221_CR52","first-page":"27","volume-title":"Immunotherapy of Malignant Diseases","author":"A B Skotnicki","year":"1978","unstructured":"Skotnicki A B, Thomson A E R, Tisdale M J: The influence of calf thymus extract on lymphocyte populations in chronic lymphocytic leukemia, in Rainer H (ed):Immunotherapy of Malignant Diseases, pp. 27\u201330. Stuttgart, New York, Schattauer (1978)."},{"key":"BF02985221_CR53","unstructured":"Marjanska-Radziszewska J, Bicz-Ciecialowa M, Szmigiel Z, Skotnicki A B: Application of the thymic extract in patient suffering from Hodgkin\u2019s disease, in:XI Congress of the Polish Haematological Society, Abstracts, p. 118. Gdansk (1975)."},{"key":"BF02985221_CR54","first-page":"187","volume":"48","author":"A Slowik-Gabryelska","year":"1980","unstructured":"Slowik-Gabryelska A, Krzysko R: The relationship between the dose of TFX and the clinical course of primary lung cancer.Pneum Pol\n                  48, 187 (1980).","journal-title":"Pneum Pol"},{"key":"BF02985221_CR55","first-page":"152","volume":"7","author":"R Krzysko","year":"1981","unstructured":"Krzysko R, Slowik-Gabryelska A: TFX in primary bronchial cancer and some indices of its activity.Immun Pol\n                  7, 152 (1981).","journal-title":"Immun Pol"},{"key":"BF02985221_CR56","first-page":"18","volume":"17","author":"G Turowski","year":"1976","unstructured":"Turowski G, Cybulski L, Politowski M, Turaszwili T, Zubel M: First trials of immunopotentiation by thymic extract (TFX) in surgical patients with malignant disease.Acta med pol\n                  17, 18 (1976).","journal-title":"Acta med pol"},{"key":"BF02985221_CR57","first-page":"47","volume":"28","author":"A Urban","year":"1977","unstructured":"Urban A, Turowski G, Cybulski L: The histological changes of the colon and rectum cancers stroma observed in patients after immunopotentiation by thymus extract (TFX).Patol Pol\n                  28, 47 (1977).","journal-title":"Patol Pol"},{"key":"BF02985221_CR58","first-page":"47","volume":"15","author":"L Cybulski","year":"1976","unstructured":"Cybulski L, Turowski G, Politowski M, Urban A, Turaszwili T, Zubek M: Initial observations on the application of thymus extract (TFX) in patients with alimentary tract neoplasm.Pol med Sci Hist Bull\n                  15, 47 (1976).","journal-title":"Pol med Sci Hist Bull"},{"key":"BF02985221_CR59","unstructured":"Cybulski L, Turowski G: The effect of TFX on surgical therapy. Clinical consideration based on 14 years observations, in Chyrek-Borowska S (ed):Immunomodulation (Bialowieza), p. 42. Polish Immunological Society (1987)."},{"key":"BF02985221_CR60","first-page":"47","volume":"1","author":"J Hryniewiecki","year":"1985","unstructured":"Hryniewiecki J, Kiczka W: Regression of gastric cancer with metastases following immunostimulation treatment confirmed by autopsy.Int J Immunother\n                  1, 47 (1985).","journal-title":"Int J Immunother"},{"key":"BF02985221_CR61","first-page":"37","volume":"17","author":"Z Chlap","year":"1984","unstructured":"Chlap Z, Jaszcz W, Turowski G: The influence of calf thymus extract (TFX) on growth of the subcutaneous transplant of Ehrlich\u2019s carcinoma.Mat med pol\n                  17, 37 (1984).","journal-title":"Mat med pol"},{"key":"BF02985221_CR62","first-page":"497","volume":"47","author":"A Gorski","year":"1982","unstructured":"Gorski A, Korczak-Kowalska G, Nowaczyk M, Gaciong Z, Skopinska-Rozewska E: Thymosin, an immunomodulator of antibody production in man.Immunology\n                  47, 497 (1982).","journal-title":"Immunology"},{"key":"BF02985221_CR63","first-page":"825","volume":"15","author":"A Gorski","year":"1983","unstructured":"Gorski A, Paczwk L, Rancewicz A, Mokrzycka-Michalik M, Korczak-Kowalska G, Dierzanowska D: Factors affecting immunoglobulin production of lymphocytes from renal allograft recipients.Transplantn Proc\n                  15, 825 (1983).","journal-title":"Transplantn Proc"},{"key":"BF02985221_CR64","first-page":"1339","volume":"17","author":"A Gorski","year":"1985","unstructured":"Gorski A, Orlowski T, Korczak-Kowalska G, Nowaczyk M, Wasik M, Podobinska I: Suppression of immune functionsin vivo with cyclophosphamide: enhancement of suppression by thymosin (TFX).Transplantn Proc\n                  17, 1339 (1985).","journal-title":"Transplantn Proc"},{"key":"BF02985221_CR65","unstructured":"Dabrowski M P, Dabrowska-Bernstein B K (eds):Immunoregulatory Role of Thymus. Boca Raton, FL, CRC Press, in press."},{"key":"BF02985221_CR66","first-page":"1089","volume":"39","author":"B K Dabrowska-Bernstein","year":"1984","unstructured":"Dabrowska-Bernstein B K, Dabrowski M P, Stasiak A, Wasowska B, Brzosko W J: Immunotherapy of the chronic active viral hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa).Pol Tyg Lek\n                  39, 1089 (1984).","journal-title":"Pol Tyg Lek"},{"key":"BF02985221_CR67","unstructured":"Dworniak D, Baj Z, Pokoca L, Majewska E, Dribnik S, Tch\u00f3rzewski H, Zeman K: The use of TFX in the treatment of patients with chronic active hepatitis B, in Chyrek-Borowska S (ed):Immunomodulation (Bialowieza), p. 40. Polish Immunological Society (1987)."},{"key":"BF02985221_CR68","unstructured":"Fiedorowicz-Fabrycy I, Sochacka-Kuzko B, Ostanek L, Glab-Kordecka E, Urasinski I: The effect of immunomodulatory treatment in patients with connective tissue diseases, in Chyrek-Borowska S (ed):Immunomodulation (Bialowieza), p. 39. Polish Immunological Society (1987)."},{"key":"BF02985221_CR69","first-page":"1","volume":"17","author":"J Aleksandrowicz","year":"1976","unstructured":"Aleksandrowicz J, Skotnicki A B: The role of the thymus and thymic humoral factors in immunotherapy of aplastic and proliferative diseases of the haemopoietic system.Acta med pol\n                  17, 1 (1976).","journal-title":"Acta med pol"},{"key":"BF02985221_CR70","first-page":"267","volume":"63","author":"J Aleksandrowicz","year":"1977","unstructured":"Aleksandrowicz J, Blicharski J, Cichocki T, Dobrowolski J, Kwiatkowski A, Lisiewicz J, Sasiadek U, Skotnicki A B, Warzewska-Czyzewska M: The effect of calf thymus extract on surface structure and lysosomal apparatus in lymphocytes of patients with chronic lymphocytic leukemia.Haematologica\n                  63, 267 (1977).","journal-title":"Haematologica"},{"key":"BF02985221_CR71","first-page":"73","volume":"29","author":"A B Skotnicki","year":"1980","unstructured":"Skotnicki A B: Thymus extract \u2014 TFX \u2014 in the treatment of bone marrow hypoplasia.Erfahrungsheilkund\n                  29, 73 (1980).","journal-title":"Erfahrungsheilkund"},{"key":"BF02985221_CR72","first-page":"103","volume-title":"Thymic Factor Therapy","author":"A Gorski","year":"1984","unstructured":"Gorski A, Podobinska I, Nowaczyk M, Korczak-Kowalska G: Immunomodulatory effects of thymic factor (TFX) on the interactions between T- and B- cells and their sensitivity to immunosuppressive agents, in Byron N A, Hobbs J R (eds):Thymic Factor Therapy, pp. 103\u2013112. New York, Raven Press (1984)."},{"key":"BF02985221_CR73","first-page":"500","volume":"54","author":"A B Skotnicki","year":"1975","unstructured":"Skotnicki A B, Aleksandrowicz J, Lisiewicz J: Effect of the calf thymus extract on immunologic reactivity in patients with hypogammaglobulinaemia.Boll 1st Sieroter Milan\n                  54, 500 (1975).","journal-title":"Boll 1st Sieroter Milan"},{"key":"BF02985221_CR74","first-page":"1139","volume":"40","author":"B Romanski","year":"1985","unstructured":"Romanski B, Montowska L, Zbikowska-Gotz M, Staszynska M: Treatment of selected patients with acquired immune deficiency using preparation TFX-Polfa.Pol Tyg Lek\n                  40, 1139 (1985).","journal-title":"Pol Tyg Lek"},{"key":"BF02985221_CR75","unstructured":"Moniuszko T, Blasiak J, Chyrek-Borowska S: The results of immunomodulatory treatment in patients with endogenous bronchial asthma, in Chyrek-Borowska S (ed):Immunomodulation (Bialowieza), p. 48. Polish Immunological Society (1987)."},{"key":"BF02985221_CR76","unstructured":"Siwinska-Golebiowska H, Smogorzewska E, Domanska J: Thein vitro andin vivo immunomodulatory effects of Levamisole and TFX in children with primary and secondary immunodeficiency states, in Chyrek-Borowska S (ed):Immunomodulation (Bialowieza), p. 52. Polish Immunological Society (1987)."},{"key":"BF02985221_CR77","unstructured":"Skotnicki A B, Dabrowska-Bernstein B K, Dabrowski M P: Perspectives in human humoral thymotherapy and the existing clinical experience with TFX-Polfa, in Kouttab N (ed):Thymic Hormones: Immunological Mechanisms and Therapeutic Action. New York, Marcel Dekker, in press."},{"key":"BF02985221_CR78","first-page":"573","volume":"42","author":"A B Skotnicki","year":"1985","unstructured":"Skotnicki A B: Influence of immunomodulators in interleukin 2 production.Przeg Lek\n                  42, 573 (1985).","journal-title":"Przeg Lek"},{"key":"BF02985221_CR79","first-page":"183","volume":"12","author":"A B Skotnicki","year":"1987","unstructured":"Skotnicki A B: The role of interleukin 2 in immune response.Immun Pol\n                  12, 183 (1987).","journal-title":"Immun Pol"},{"key":"BF02985221_CR80","unstructured":"Skotnicki A B: Thymic hormones and lymphokines.Drugs Today, in press."},{"key":"BF02985221_CR81","unstructured":"Kornaszewski W, Lurhuma K, Skotnicki A B: The immunoprophylaxis and\/or immunotherapy with thymic hormones in HIV-seropositive asymptomatic subjects and in AIDS patients, in2nd International Symposium on AIDS and Associated Cancers in Africa, Naples, Oct. 7\u20139, Abstracts, p. 15 (1987)."}],"container-title":["Medical Oncology and Tumor Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02985221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02985221\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02985221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:25:11Z","timestamp":1744161911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02985221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,3]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,3]]}},"alternative-id":["BF02985221"],"URL":"https:\/\/doi.org\/10.1007\/bf02985221","relation":{},"ISSN":["0736-0118"],"issn-type":[{"value":"0736-0118","type":"print"}],"subject":[],"published":{"date-parts":[[1989,3]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}